drugset / Trial / NCT03773055
Phase II Clinical Trial of NPC-06 in Patients With Neuropathic Pain in Cancer
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this trial is to investigate the efficiency of pain relief and the safety of NPC-06 for the neuropathic pain associated with cancer, in addition to explore the effective concentration of NPC-06.
Timeline
- Start
- 2019-04-03
- Primary completion
- 2020-09-30
- Completion
- 2020-09-30
Outcome
Outcome not reported
Stopped (Enrollment): “Low recruitment”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | NPC-06 | Unknown | 6 mg | Intravenous |
| Comparator | NPC-06 | Unknown | 9 mg | Intravenous |